These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28973315)

  • 1. Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2.
    Mukherjee D; Lad EM; Vann RR; Jaffe SJ; Clemons TE; Friedlander M; Chew EY; Jaffe GJ; Farsiu S;
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO291-BIO299. PubMed ID: 28973315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
    Sallo FB; Leung I; Clemons TE; Peto T; Chew EY; Pauleikhoff D; Bird AC;
    Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S27-S32. PubMed ID: 28541963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Relevance of Hyper-Reflectivity in Macular Telangiectasia Type 2.
    Tzaridis S; Friedlander M;
    Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):6. PubMed ID: 33661283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study.
    Runkle AP; Kaiser PK; Srivastava SK; Schachat AP; Reese JL; Ehlers JP
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3683-3689. PubMed ID: 28727884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
    Pauleikhoff D; Gunnemann F; Book M; Rothaus K
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.
    Pauleikhoff D; Bonelli R; Dubis AM; Gunnemann F; Rothaus K; Charbel Issa P; Heeren TF; Peto T; Clemons TE; Chew EY; Bird AC; Sallo FB;
    Acta Ophthalmol; 2019 Nov; 97(7):e998-e1005. PubMed ID: 30968592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normative data set identifying properties of the macula across age groups: integration of visual function and retinal structure with microperimetry and spectral-domain optical coherence tomography.
    Sabates FN; Vincent RD; Koulen P; Sabates NR; Gallimore G
    Retina; 2011; 31(7):1294-302. PubMed ID: 21358460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond Performance Metrics: Automatic Deep Learning Retinal OCT Analysis Reproduces Clinical Trial Outcome.
    Loo J; Clemons TE; Chew EY; Friedlander M; Jaffe GJ; Farsiu S
    Ophthalmology; 2020 Jun; 127(6):793-801. PubMed ID: 32019699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.
    Heeren TFC; Kitka D; Florea D; Clemons TE; Chew EY; Bird AC; Pauleikhoff D; Charbel Issa P; Holz FG; Peto T
    Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S20-S26. PubMed ID: 28541959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating Retinal Sensitivity Using Optical Coherence Tomography With Deep-Learning Algorithms in Macular Telangiectasia Type 2.
    Kihara Y; Heeren TFC; Lee CS; Wu Y; Xiao S; Tzaridis S; Holz FG; Charbel Issa P; Egan CA; Lee AY
    JAMA Netw Open; 2019 Feb; 2(2):e188029. PubMed ID: 30735236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-stage macular telangiectasia type 2 vascular abnormalities are associated with interdigitation zone disruption.
    Ong JX; Zandi R; Fawzi AA
    PLoS One; 2021; 16(11):e0259811. PubMed ID: 34767582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microperimetry Features of Geographic Atrophy Identified With En Face Optical Coherence Tomography.
    Pilotto E; Convento E; Guidolin F; Abalsamo CK; Longhin E; Parrozzani R; Midena E
    JAMA Ophthalmol; 2016 Aug; 134(8):873-9. PubMed ID: 27253760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive multi-imaging biomarkers relevant for visual acuity in idiopathic macular telangiectasis type 1.
    Guo J; Tang W; Ye X; Wu H; Xu G; Liu W; Zhang Y
    BMC Ophthalmol; 2018 Mar; 18(1):69. PubMed ID: 29506510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular Telangiectasia type 2: multimodal assessment of retinal function and microstructure.
    Ledolter AA; Ristl R; Palmowski-Wolfe AM; Montuoro A; Deak GG; Sacu S; Holder GE; Schmidt-Erfurth U; Ritter M
    Acta Ophthalmol; 2022 Sep; 100(6):e1240-e1252. PubMed ID: 34854225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive optics microperimetry and OCT images show preserved function and recovery of cone visibility in macular telangiectasia type 2 retinal lesions.
    Wang Q; Tuten WS; Lujan BJ; Holland J; Bernstein PS; Schwartz SD; Duncan JL; Roorda A
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):778-86. PubMed ID: 25587056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
    Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
    Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of spectral-domain optical coherence tomography features in assessment of visual prognosis in eyes with acute welding arc maculopathy.
    Zhang C; Dang G; Zhao T; Wang D; Su Y; Qu Y
    Int Ophthalmol; 2019 May; 39(5):1081-1088. PubMed ID: 29651692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal structural alterations and macular sensitivity in idiopathic macular telangiectasia type 1.
    Takayama K; Ooto S; Tamura H; Yamashiro K; Otani A; Tsujikawa A; Yoshimura N
    Retina; 2012 Oct; 32(9):1973-80. PubMed ID: 22487581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Helb HM; Holz FG; Scholl HP;
    Am J Ophthalmol; 2008 Jan; 145(1):169-175. PubMed ID: 17981256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.